A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia

View Dataset
Ipsen

Description

The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.

Citations (0)

Mentions (0)

Metrics

Dataset Index

1.0

FAIR Score

46%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Vivli

Assigned Domain

Subfield

Cognitive Neuroscience

Field

Neuroscience

Domain

Life Sciences

Confidence Score

47%

Source

Scholar Data Model

Keywords

Conditions: Cervical DystoniaInterventions: Botulinum toxin type AInterventions: Placebo

Normalization Factors

FT

15.38

CTw

1.00

MTw

1.00